Grow Your Wealth
with Mutual Funds
DSP Healthcare Fund Regular-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 2,891.8 Cr.
NAV as on 24 jul, 2026
₹ 43.34
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
DSP Healthcare Fund Regular-growth
Inception Date
30 Nov 2018
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
93.24%
Cash
6.76%
Portfolio Updated on: 13 Jul, 2026
Sector Allocations
Equity
Healthcare
Financial
Portfolio Updated on: 24 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Cipla Ltd | Healthcare | Equity | 1.00% |
| Ipca Laboratories Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Cipla Ltd | Healthcare | Equity | 9.16% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.85% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.85% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Cipla Ltd | Healthcare | Equity | 8.63% |
| Cipla Ltd | Healthcare | Equity | 8.63% |
Debt & Credit Risk Analysis
| Alpha | -1.36% |
| Beta | 0.84% |
| Sharpe Ratio | 0.89% |
| Standard Deviation | 15.08% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 14.17% | NA | 6.12% |
| 6 Months | 16.04% | NA | 12.92% |
| 9 Months | 9.46% | NA | 4.47% |
| 1 Year | 6.80% | 6.80% | 6.04% |
| 2 Years | 20.28% | 9.67% | 24.93% |
| 3 Years | 73.36% | 20.13% | 25.71% |
| 5 Years | 92.71% | 14.02% | 19.91% |
| 7 Years | 338.69% | 23.52% | NA |
DSP Healthcare Fund Regular-growth is one Equity mutual fund offered by DSP Mutual Fund. Launched on 30 Nov 2018, the fund aims Long term capital growth. Investment in equity and equity related Securities of healthcare and pharmaceutical companies. It manages assets worth ₹2,891.8 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.94%.
Chirag Dagli has experience Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
| SBI Healthcare Opportunities Fund-idcw | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-idcw | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from DSP Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Regular-idcw | 2,891.8 | +1.88% | +14.17% | +16.04% | +6.80% | +20.13% | +14.02% |
| DSP Healthcare Fund Direct-idcw | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Regular-idcw | 2,891.8 | +1.88% | +14.17% | +16.04% | +6.80% | +20.13% | +14.02% |
| DSP Healthcare Fund Direct-idcw | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth | 7,898.2 | +0.77% | +9.68% | +14.42% | +5.29% | +18.85% | +12.13% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +0.84% | +9.91% | +14.91% | +6.23% | +19.92% | +13.15% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +0.84% | +9.91% | +14.91% | +6.23% | +19.92% | +13.15% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +0.77% | +9.68% | +14.42% | +5.29% | +18.85% | +12.13% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +0.33% | +11.22% | +14.67% | +5.40% | +23.49% | +15.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +0.33% | +11.22% | +14.67% | +5.40% | +23.49% | +15.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹574.88 | +23.77% | +17.21% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹399.41 | +23.77% | +17.21% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹46.62 | +24.54% | +16.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.15 | +24.54% | +16.25% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹496.93 | +22.49% | +15.98% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹313.04 | +22.49% | +15.98% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.04 | +21.75% | +15.57% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 24 Jul 2026 | ₹43.34 |
| 23 Jul 2026 | ₹43.34 |
| 22 Jul 2026 | ₹43.50 |
| 21 Jul 2026 | ₹44.12 |
| 20 Jul 2026 | ₹44.12 |
| 17 Jul 2026 | ₹44.03 |
| 16 Jul 2026 | ₹44.76 |
| 15 Jul 2026 | ₹44.41 |
| 14 Jul 2026 | ₹44.17 |
| 13 Jul 2026 | ₹44.33 |
| 10 Jul 2026 | ₹44.34 |
| 09 Jul 2026 | ₹44.07 |
| 08 Jul 2026 | ₹43.37 |
| 07 Jul 2026 | ₹43.80 |
| 06 Jul 2026 | ₹43.99 |
| 02 Jul 2026 | ₹43.59 |
| 01 Jul 2026 | ₹43.16 |
| 30 Jun 2026 | ₹43.09 |
| 29 Jun 2026 | ₹42.86 |
| 25 Jun 2026 | ₹42.63 |
| 24 Jun 2026 | ₹42.54 |
| 23 Jun 2026 | ₹42.23 |
| 22 Jun 2026 | ₹41.65 |
| 18 Jun 2026 | ₹41.28 |
| 17 Jun 2026 | ₹41.08 |
| 16 Jun 2026 | ₹41.34 |
| 12 Jun 2026 | ₹41.68 |
| 11 Jun 2026 | ₹41.73 |
| 10 Jun 2026 | ₹41.44 |
| 09 Jun 2026 | ₹41.65 |
Portfolio Updated on: 26 Jul, 2026
Fund Growth & Size Analysis
+₹2,891.8 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
DSP Healthcare Fund Regular-growth Returns Comparison
Compare DSP Healthcare Fund Regular-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
DSP Healthcare Fund Re....
No funds found for your search.
DSP Healthcare Fund Regular-growth FAQ'S
- Sharpe Ratio: 0.89%
- Standard Deviation: 15.08%
- Beta: 0.84%
- Alpha: -1.36%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under DSP Healthcare Fund Regular-growth stand at approximately ₹ 2,891.8 crore.
The DSP Healthcare Fund Regular-growth has delivered the following short-term performance:
- 3 Months Return: 14.17%
- 6 Months Return: 16.04%
The historical growth of the DSP Healthcare Fund Regular-growth is reflected through its CAGR returns:
- 3 Year CAGR: 20.13%
- 5 Year CAGR: 14.02%
- Return Since Launch: 21.12%
The portfolio of DSP Healthcare Fund Regular-growth is distributed across different asset classes as follows:
- Equity: 93.24%
- Other Assets: 6.76%
The DSP Healthcare Fund Regular-growth is managed by Chirag Dagli, representing DSP Mutual Fund.
The DSP Healthcare Fund Regular-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of DSP Healthcare Fund Regular-growth include:
- Cipla Ltd – represents 1.00% of the portfolio
- Ipca Laboratories Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Cipla Ltd – represents 9.16% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 8.85% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 8.85% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Cipla Ltd – represents 8.63% of the portfolio
- Cipla Ltd – represents 8.63% of the portfolio
Major sector exposures in DSP Healthcare Fund Regular-growth are:
- Healthcare – accounts for 1,033.55% of the portfolio
- Financial – accounts for 17.90% of the portfolio
